Pediatric Diabetes
Some microRNA species increase odds for glycemic failure in youth-onset type 2 diabetes
Circulating levels of some microRNA species may predict response to diabetes treatment and changes in beta-cell function among children and adolescents with type 2 diabetes, according to findings from the TODAY study.
FDA approves dapagliflozin for children and adolescents with type 2 diabetes
The FDA approved the SGLT2 inhibitor dapagliflozin to improve glycemic control among children and adolescents aged 10 years and older with type 2 diabetes, according to an industry press release.
Top in endocrinology: FDA warns about noninvasive glucose readings; diabetes in children
The FDA issued a warning to people with diabetes not to use smartwatches or smart rings that do not pierce the skin for measuring blood glucose because the readings could be inaccurate.
New-onset type 1 diabetes cases among children decline in 2022 after sharp increase
Rates of new-onset type 1 diabetes among children fell back to pre-pandemic levels in 2022 after sharply increasing in 2021, according to a population-wide analysis of data from Scotland published in Diabetes Care.
Baseline HbA1c over 6% greatly increases type 2 diabetes risk for adolescents with obesity
The risk for developing type 2 diabetes is substantially higher for adolescents with overweight or obesity and an HbA1c of at least 6.1% compared with those with an HbA1c of 5.5% or less, according to study data.
CGM use less likely for children with type 1 diabetes living in rural vs. urban areas
Children with type 1 diabetes living in small or isolated rural towns are less likely to use continuous glucose monitoring than those living in urban areas, according to data published in Diabetes Care.
Teplizumab preserves beta-cell function for children with new-onset type 1 diabetes
Children with new-onset type 1 diabetes had better preservation of beta-cell function with two 12-day courses of teplizumab compared with those receiving placebo, according to findings published in The New England Journal of Medicine.
Baseline glucose, increasing BMI predict progression to type 2 diabetes for children
Higher initial glucose levels and increasing BMI over time could serve as predictors of progression from prediabetes to type 2 diabetes for children and adolescents, according to findings published in the Journal of the Endocrine Society.
New-onset diabetes diagnoses increased for youths during COVID-19 pandemic
Incidence rates for both type 1 and type 2 diabetes diagnoses increased among children and adolescents during the COVID-19 pandemic compared with 2016 to 2019, according to study findings published in JAMA Network Open.
VIDEO: Tips for keeping children with type 1 diabetes safe at school
SAN DIEGO — In this video exclusive, Anastasia Albanese-O’Neill, PhD, APRN, RN, CDCES, discusses important resources for schools to better care for children with type 1 diabetes.